Literature DB >> 30214873

Mechanically expanding transcatheter aortic valves: pros and cons of a unique device technology.

Kenan Yalta1, Muhammet Gurdogan1, Cafer Zorkun1, Yekta Gurlertop1.   

Abstract

Year:  2018        PMID： 30214873      PMCID： PMC6129820          DOI： 10.21037/cdt.2018.04.06

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  24 in total

1.  Early hypoattenuated leaflet thickening and restricted leaflet motion of a Lotus transcatheter heart valve detected by 4D computed tomography angiography.

Authors:  Simon Schoechlin; Philipp Ruile; Franz-Josef Neumann; Gregor Pache
Journal:  EuroIntervention       Date:  2015-09       Impact factor: 6.534

2.  Thrombotic complications associated with transcatheter aortic valve implantation: the role of Kounis hypersensitivity-associated thrombotic syndrome.

Authors:  George D Soufras; George Hahalis; Nicholas G Kounis
Journal:  Cardiovasc Pathol       Date:  2014-06-21       Impact factor: 2.185

Review 3.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  Circulation       Date:  2017-03-15       Impact factor: 29.690

4.  Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).

Authors:  Alaide Chieffo; Gill Louise Buchanan; Nicolas M Van Mieghem; Didier Tchetche; Nicolas Dumonteil; Azeem Latib; Robert M A van der Boon; Olivier Vahdat; Bertrand Marcheix; Bruno Farah; Patrick W Serruys; Jean Fajadet; Didier Carrié; Peter P T de Jaegere; Antonio Colombo
Journal:  J Am Coll Cardiol       Date:  2013-01-16       Impact factor: 24.094

5.  5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.

Authors:  Samir R Kapadia; Martin B Leon; Raj R Makkar; E Murat Tuzcu; Lars G Svensson; Susheel Kodali; John G Webb; Michael J Mack; Pamela S Douglas; Vinod H Thourani; Vasilis C Babaliaros; Howard C Herrmann; Wilson Y Szeto; Augusto D Pichard; Mathew R Williams; Gregory P Fontana; D Craig Miller; William N Anderson; Jodi J Akin; Michael J Davidson; Craig R Smith
Journal:  Lancet       Date:  2015-03-15       Impact factor: 79.321

6.  Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidence.

Authors:  Sameer Arora; John P Vavalle
Journal:  Ann Cardiothorac Surg       Date:  2017-09

7.  Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI).

Authors:  Holger Eggebrecht; Beatriz Vaquerizo; Cesar Moris; Eduardo Bossone; Johannes Lämmer; Martin Czerny; Andreas Zierer; Holger Schröfel; Won-Keun Kim; Thomas Walther; Smita Scholtz; Tanja Rudolph; Christian Hengstenberg; Jörg Kempfert; Marco Spaziano; Thierry Lefevre; Sabine Bleiziffer; Joachim Schofer; Julinda Mehilli; Moritz Seiffert; Christoph Naber; Fausto Biancari; Dennis Eckner; Charles Cornet; Thibault Lhermusier; Raphael Philippart; Antti Siljander; Alfredo Giuseppe Cerillo; Daniel Blackman; Alaide Chieffo; Philipp Kahlert; Katarzyna Czerwinska-Jelonkiewicz; Piotr Szymanski; Uri Landes; Ran Kornowski; Augusto D'Onofrio; Carl Kaulfersch; Lars Søndergaard; Darren Mylotte; Rajendra H Mehta; Ole De Backer
Journal:  Eur Heart J       Date:  2018-02-21       Impact factor: 29.983

8.  1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.

Authors:  Ian T Meredith; Darren L Walters; Nicolas Dumonteil; Stephen G Worthley; Didier Tchétché; Ganesh Manoharan; Daniel J Blackman; Gilles Rioufol; David Hildick-Smith; Robert J Whitbourn; Thierry Lefèvre; Rüdiger Lange; Ralf Müller; Simon Redwood; Ted E Feldman; Dominic J Allocco; Keith D Dawkins
Journal:  JACC Cardiovasc Interv       Date:  2016-02-22       Impact factor: 11.195

9.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

10.  Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study.

Authors:  Volkmar Falk; Jochen Wöhrle; David Hildick-Smith; Sabine Bleiziffer; Daniel J Blackman; Mohamed Abdel-Wahab; Ulrich Gerckens; Axel Linke; Hüseyin Ince; Peter Wenaweser; Dominic J Allocco; Keith D Dawkins; Nicolas M Van Mieghem
Journal:  Eur Heart J       Date:  2017-12-01       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.